On January 1, 2024 (in approximately five months), the Corporate Transparency Act (CTA) takes effect.  In my previous article , I reviewed why the Act was passed, which entities were affected by the Act, who must file, who is exempt from filing, and when the filings needed to be made.  In this post, I will review what reports need to be filed, the penalties for not filing, and what businesses should do now to prepare for the future. To...

Read more

You may have heard murmurs about significant new prohibitions on non-compete covenants (“non-competes”) and might be concerned about how these developments could threaten your current, past and future deals. In the M&A context, buyers often rely on non-competes as part of a broader strategy to retain the value of the businesses they are purchasing. If any of the target company’s executives, salespeople, owners, developers of IP or others who hold important client relationships or trade secrets can easily leave...

Read more

On 15 September 2023, the Commission Implementing Regulation (EU) 2023/1773 (“Implementing Regulation”) was published in the Official Journal of the EU. The Implementing Regulation governs the application of Regulation (EU) 2023/956 establishing a carbon border adjustment mechanism (“CBAM” or “CBAM-Regulation”) during the transitional period from 1 October 2023 until 31 December 2025. During this transitional period, obligations under the CBAM-Regulation are limited to quarterly reporting duties regarding embedded emissions of relevant goods listed in the Annexes. Obligations to surrender emission certificates will apply from 1...

Read more

Commission calls for risk assessment across critical technologies As part of the broader European Economic Security Strategy, the European Commission has adopted a recommendation advocating for collective risk assessments in four critical technology areas. These include advanced semiconductors, artificial intelligence, quantum computing and biotechnologies. Based on their potential to transform the future of technology; risk of civil-military fusion; and risk of misuse in violation of human rights, these areas were found to face particularly strong risks in relation to technology security and technology...

Read more

The U.S. Food and Drug Administration (FDA) is making efforts to modernize both the 510(k) approval process for medical devices and study designs for drugs and biologics. On September 7, 2023, the FDA Center for Devices and Radiological Health (CDRH) issued three draft device guidances: 1) Best Practices for Selecting a Predicate Device to Support a Premarket Notification Submission; 2) Recommendations for the Use of Clinical Data in Premarket Notification Submissions; and 3) Evidentiary Expectations for 510(k) Implant Devices. On...

Read more

After releasing a model treaty provision in July, the OECD has published a multilateral convention to facilitate the implementation of the Pillar Two Subject to Tax Rule (Convention) on 3 October 2023. Similar to the Multilateral Instrument (MLI) that enabled faster implementation of several BEPS measures, the Convention aims at accelerating the implementation of the Subject to Tax Rule (STTR), which is part of the OECD's Pillar Two measures. Similar to the MLI, the STTR only impacts an existing bilateral...

Read more